These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6628452)

  • 1. Gaucher disease--Norrbottnian type. Neurodevelopmental, neurological, and neurophysiological aspects.
    Blom S; Erikson A
    Eur J Pediatr; 1983 Sep; 140(4):316-22. PubMed ID: 6628452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gaucher disease--Norrbottnian type (III). Neuropaediatric and neurobiological aspects of clinical patterns and treatment.
    Erikson A
    Acta Paediatr Scand Suppl; 1986; 326():1-42. PubMed ID: 3296644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gaucher disease--Norrbottnian type. I. General clinical description.
    Dreborg S; Erikson A; Hagberg B
    Eur J Pediatr; 1980 Mar; 133(2):107-18. PubMed ID: 7363908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematological findings in the Norrbottnian type of Gaucher disease.
    Tibblin E; Dreborg S; Erikson A; Håkansson G; Svennerholm L
    Eur J Pediatr; 1982 Nov; 139(3):187-91. PubMed ID: 7160406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gaucher disease (type III): intellectual profile.
    Erikson A; Karlberg J; Skogman AL; Dreborg S
    Pediatr Neurol; 1987; 3(2):87-91. PubMed ID: 3508057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme infusion therapy of the Norrbottnian (type 3) Gaucher disease.
    Erikson A; Aström M; Månsson JE
    Neuropediatrics; 1995 Aug; 26(4):203-7. PubMed ID: 8544959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapidly progressive type III Gaucher disease: deterioration following partial splenectomy.
    Kyllerman M; Conradi N; Månsson JE; Percy AK; Svennerholm L
    Acta Paediatr Scand; 1990 Apr; 79(4):448-53. PubMed ID: 2349880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gaucher disease--Norrbottnian type. Ocular abnormalities.
    Erikson A; Wahlberg I
    Acta Ophthalmol (Copenh); 1985 Apr; 63(2):221-5. PubMed ID: 4003050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropathology of the Norrbottnian type of Gaucher disease. Morphological and biochemical studies.
    Conradi NG; Sourander P; Nilsson O; Svennerholm L; Erikson A
    Acta Neuropathol; 1984; 65(2):99-109. PubMed ID: 6524300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactions of vessel walls and brain parenchyma to the accumulation of Gaucher cells in the Norrbottnian type (type III) of Gaucher disease.
    Conradi NG; Kalimo H; Sourander P
    Acta Neuropathol; 1988; 75(4):385-90. PubMed ID: 3364161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Norrbottnian type of Gaucher disease--clinical, biochemical and molecular biology aspects: successful treatment with bone marrow transplantation.
    Svennerholm L; Erikson A; Groth CG; Ringdén O; Månsson JE
    Dev Neurosci; 1991; 13(4-5):345-51. PubMed ID: 1817041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gaucher disease of the Norrbottnian type (type III). Phenotypic manifestations.
    Svennerholm L; Dreborg S; Erikson A; Groth CG; Hillborg PO; Håkansson G; Nilsson O; Tibblin E
    Prog Clin Biol Res; 1982; 95():67-94. PubMed ID: 6812091
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of splenectomy on destructive bone changes in children with chronic (Type I) Gaucher disease.
    Ashkenazi A; Zaizov R; Matoth Y
    Eur J Pediatr; 1986 Apr; 145(1-2):138-41. PubMed ID: 3732318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Norrbottnian clinical variant of Gaucher disease in Southern Italy.
    Sestito S; Filocamo M; Ceravolo F; Falvo F; Grisolia M; Moricca MT; Cantaffa R; Grossi S; Strisciuglio P; Concolino D
    J Hum Genet; 2017 Apr; 62(4):507-511. PubMed ID: 28003644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and biochemical outcome of marrow transplantation for Gaucher disease of the Norrbottnian type.
    Erikson A; Groth CG; Månsson JE; Percy A; Ringdén O; Svennerholm L
    Acta Paediatr Scand; 1990; 79(6-7):680-5. PubMed ID: 2386062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ten years' experience of enzyme infusion therapy of Norrbottnian (type 3) Gaucher disease.
    Erikson A; Forsberg H; Nilsson M; Aström M; Månsson JE
    Acta Paediatr; 2006 Mar; 95(3):312-7. PubMed ID: 16497642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical aspects of early-stage neurological forms of Gaucher disease].
    Mignot C
    Rev Med Interne; 2006 Mar; 27 Suppl 1():S14-7. PubMed ID: 16644395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The occurrence of psychosine and other glycolipids in spleen and liver from the three major types of Gaucher's disease.
    Nilsson O; Månsson JE; Håkansson G; Svennerholm L
    Biochim Biophys Acta; 1982 Sep; 712(3):453-63. PubMed ID: 7126619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed growth and puberty in patients with Gaucher disease type 1: natural history and effect of splenectomy and/or enzyme replacement therapy.
    Kauli R; Zaizov R; Lazar L; Pertzelan A; Laron Z; Galatzer A; Phillip M; Yaniv Y; Cohen IJ
    Isr Med Assoc J; 2000 Feb; 2(2):158-63. PubMed ID: 10804944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A severity scoring tool to assess the neurological features of neuronopathic Gaucher disease.
    Davies EH; Surtees R; DeVile C; Schoon I; Vellodi A
    J Inherit Metab Dis; 2007 Oct; 30(5):768-82. PubMed ID: 17876722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.